A
Anatoly I. Miroshnikov
Researcher at Russian Academy of Sciences
Publications - 118
Citations - 1361
Anatoly I. Miroshnikov is an academic researcher from Russian Academy of Sciences. The author has contributed to research in topics: Nucleoside & Purine nucleoside phosphorylase. The author has an hindex of 19, co-authored 107 publications receiving 1235 citations. Previous affiliations of Anatoly I. Miroshnikov include Moscow State University.
Papers
More filters
Journal ArticleDOI
S,X-acetals in nucleoside chemistry. III. Synthesis of 2'- and 3'-O-azidomethyl derivatives of ribonucleosides.
TL;DR: 2′- and 3′-O-azidomethyl derivatives of ribonucleosides were obtained by splitting the corresponding methylthiomethylene derivatives of Ribonucleusides with bromine or SO2Cl2 followed by lithium azide treatment.
Journal ArticleDOI
Enzymatic transglycosylation of natural and modified nucleosides by immobilized thermostable nucleoside phosphorylases from Geobacillus stearothermophilus
TL;DR: Owing to the high catalytic activity, thermal stability, the ease of application, and the possibility of repeated use, the immobilized preparations of thermostable nucleoside phosphorylases are suitable for the production of pharmacologically important natural and modified nucleosides.
Journal ArticleDOI
Intestinal microbiota of salmonids and its changes upon introduction of soy proteins to fish feed
S. V. Kononova,Dmitry V. Zinchenko,Tatyana A. Muranova,Nataliya A. Belova,Anatoly I. Miroshnikov +4 more
TL;DR: This review of studies on the effect of soy proteins in feed on the intestinal microbiota of salmonids examines the impact of fat-free soy processing in feeds on salmonid health.
Journal ArticleDOI
Reverse transcription, amplification and sequencing of poliovirus rna by taq dna polymerase
TL;DR: A model for virion RNA of the poliomyelitis virus, which does not pass the stage of DNA copies during biogenesis, demonstrates that Taq DNA polymerase is capable of synthesizing 960-bp cDNA with the specific primer.
Journal ArticleDOI
Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
E. V. Moiseeva,E. M. Rapoport,N. V. Bovin,Anatoly I. Miroshnikov,A. V. Chaadaeva,M. S. Krasilshschikova,V. K. Bojenko,Caspaar Bijleveld,J. E. Van Dijk,W. Den Otter +9 more
TL;DR: It is concluded that surface β-galactoside binding proteins/galectins that are selectively expressed during mouse mammary carcinoma progression, similarly to human breast carcinomas, seem to be proper targets for asialo-GM1-vectored cytotoxics and the mouse model system might be a relevant instrument to further test novel modes of anti-breast cancer therapy.